{
    "2019-05-05": [
        [
            {
                "time": "",
                "original_text": "【国盛医药张金洋团队】年报季报验证医药从野蛮扩张到结构优化，继续推荐医药流通",
                "features": {
                    "keywords": [
                        "年报",
                        "季报",
                        "医药",
                        "野蛮扩张",
                        "结构优化",
                        "医药流通"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物股东吴冠江减持3452万股 套现约17.56亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "股东",
                        "吴冠江",
                        "减持",
                        "套现"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "海南“假疫苗”案：利润率高达80%，8000元罚款能否警世？ 其他违规处罚",
                "features": {
                    "keywords": [
                        "假疫苗",
                        "海南",
                        "利润率",
                        "罚款",
                        "违规处罚"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}